JPMA. The Journal of the Pakistan Medical Association · 2021
Correlation between serum nesfatin-1 level and severity of preeclampsia - A case control study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Skheel Aljebory Henan Dh, Abdalkareem Zinah Muayad, Jasim Adnan Mohammed
Аннотация
OBJECTIVE: To investigate if serum levels of nesfatin-1 are correlated with the severity and presence of preeclampsia.
METHODS: The case-control study was conducted at the Department of Obstetrics, Al-Yarmouk Hospital, Baghdad, Iraq, from February to December 2018, and comprised pregnant women recently diagnosed with preeclampsia at 37-40 weeks of gestation. They were divided into equal groups of non-severe preeclampsia group A and severe preeclampsia group B, and normotensive pregnant women of comparable gestational age control group C. Serum nesfatin-1 level was measured using enzyme-linked immunosorbent assay, and its relation to preeclampsia and its severity was analysed. Data was analysed using SPSS 25.
RESULTS: Of the 150 pregnant women, 50(33%) with mean age 27.8±6.4 years and gestational age 38.3±0.9 weeks were in group A, 50(33%) with mean age 28.5±6.5 years and gestational age 38.4±1.0 weeks were in group B, and 50(33%) with mean age 29.2±7.2 years and gestational age 38.4±1.0 weeks were in group C (p>0.05) Mean nesfatin-1 concentration was lower in group A and B compared to group C (p<0.001), and it was significantly lower in group B than in group A (p<0.001).
CONCLUSION: Decrease in serum nesfatin-1 level was found to be correlated with the development of preeclampsia and its severity.
METHODS: The case-control study was conducted at the Department of Obstetrics, Al-Yarmouk Hospital, Baghdad, Iraq, from February to December 2018, and comprised pregnant women recently diagnosed with preeclampsia at 37-40 weeks of gestation. They were divided into equal groups of non-severe preeclampsia group A and severe preeclampsia group B, and normotensive pregnant women of comparable gestational age control group C. Serum nesfatin-1 level was measured using enzyme-linked immunosorbent assay, and its relation to preeclampsia and its severity was analysed. Data was analysed using SPSS 25.
RESULTS: Of the 150 pregnant women, 50(33%) with mean age 27.8±6.4 years and gestational age 38.3±0.9 weeks were in group A, 50(33%) with mean age 28.5±6.5 years and gestational age 38.4±1.0 weeks were in group B, and 50(33%) with mean age 29.2±7.2 years and gestational age 38.4±1.0 weeks were in group C (p>0.05) Mean nesfatin-1 concentration was lower in group A and B compared to group C (p<0.001), and it was significantly lower in group B than in group A (p<0.001).
CONCLUSION: Decrease in serum nesfatin-1 level was found to be correlated with the development of preeclampsia and its severity.